Belgian firm will acquire controlling interest in Emory Genetics LabMain Quad on Emory University's primary Druid Hills Campus. Photo obtained via Wikimedia Commons
The firm, Eurofins Scientific, and Emory would name the joint venture EGL Genetic Diagnostics, LLC.
Emory reports that the deal is still waiting for regulatory approval.
“(Emory Genetics Laboratory), founded at Emory in 1970, and a component of the Department of Human Genetics, provides high-complexity molecular, biochemical and cytogenetic testing for rare and common genetic diseases and disorders,” the university’s press release says. “EGL currently serves more than 400 institutional clients, including hospitals and other commercial laboratories across the US and overseas.”
Emory’s Genetics Lab employs more than 100 staffers.
“This acquisition of EGL strengthens Eurofins’ growing footprint in the specialty clinical diagnostics market,” Gilles Martin, PhD, Eurofins CEO, said in Emory’s press release. “Emory Genetics Lab provides Eurofins a truly unique platform to leverage our renowned competence in genomic testing to better serve the global healthcare community. In combination with ViraCor, Boston Heart and Diatherix, EGL provides Eurofins a leading position in the most technologically-driven segment of the specialty clinical diagnostic testing market.”